IBDEI05I ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5248,0)
 ;;=L98.8^^32^343^26
 ;;^UTILITY(U,$J,358.3,5248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5248,1,3,0)
 ;;=3^Skin/Subcutaneous Tissue Disorders
 ;;^UTILITY(U,$J,358.3,5248,1,4,0)
 ;;=4^L98.8
 ;;^UTILITY(U,$J,358.3,5248,2)
 ;;=^5009594
 ;;^UTILITY(U,$J,358.3,5249,0)
 ;;=L55.0^^32^343^31
 ;;^UTILITY(U,$J,358.3,5249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5249,1,3,0)
 ;;=3^Sunburn,First Degree
 ;;^UTILITY(U,$J,358.3,5249,1,4,0)
 ;;=4^L55.0
 ;;^UTILITY(U,$J,358.3,5249,2)
 ;;=^5009212
 ;;^UTILITY(U,$J,358.3,5250,0)
 ;;=L55.1^^32^343^32
 ;;^UTILITY(U,$J,358.3,5250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5250,1,3,0)
 ;;=3^Sunburn,Second Degree
 ;;^UTILITY(U,$J,358.3,5250,1,4,0)
 ;;=4^L55.1
 ;;^UTILITY(U,$J,358.3,5250,2)
 ;;=^323553
 ;;^UTILITY(U,$J,358.3,5251,0)
 ;;=C44.02^^32^343^7
 ;;^UTILITY(U,$J,358.3,5251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5251,1,3,0)
 ;;=3^SCC Skin Lip
 ;;^UTILITY(U,$J,358.3,5251,1,4,0)
 ;;=4^C44.02
 ;;^UTILITY(U,$J,358.3,5251,2)
 ;;=^340465
 ;;^UTILITY(U,$J,358.3,5252,0)
 ;;=C44.122^^32^343^13
 ;;^UTILITY(U,$J,358.3,5252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5252,1,3,0)
 ;;=3^SCC Skin Right Eyelid
 ;;^UTILITY(U,$J,358.3,5252,1,4,0)
 ;;=4^C44.122
 ;;^UTILITY(U,$J,358.3,5252,2)
 ;;=^5001023
 ;;^UTILITY(U,$J,358.3,5253,0)
 ;;=C44.129^^32^343^4
 ;;^UTILITY(U,$J,358.3,5253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5253,1,3,0)
 ;;=3^SCC Skin Left Eyelid
 ;;^UTILITY(U,$J,358.3,5253,1,4,0)
 ;;=4^C44.129
 ;;^UTILITY(U,$J,358.3,5253,2)
 ;;=^5001024
 ;;^UTILITY(U,$J,358.3,5254,0)
 ;;=C44.222^^32^343^12
 ;;^UTILITY(U,$J,358.3,5254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5254,1,3,0)
 ;;=3^SCC Skin Right Ear/External Auric Canal
 ;;^UTILITY(U,$J,358.3,5254,1,4,0)
 ;;=4^C44.222
 ;;^UTILITY(U,$J,358.3,5254,2)
 ;;=^5001035
 ;;^UTILITY(U,$J,358.3,5255,0)
 ;;=C44.229^^32^343^3
 ;;^UTILITY(U,$J,358.3,5255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5255,1,3,0)
 ;;=3^SCC Skin Left Ear/External Auric Canal
 ;;^UTILITY(U,$J,358.3,5255,1,4,0)
 ;;=4^C44.229
 ;;^UTILITY(U,$J,358.3,5255,2)
 ;;=^5001036
 ;;^UTILITY(U,$J,358.3,5256,0)
 ;;=C44.320^^32^343^11
 ;;^UTILITY(U,$J,358.3,5256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5256,1,3,0)
 ;;=3^SCC Skin Parts of Face,Unspec
 ;;^UTILITY(U,$J,358.3,5256,1,4,0)
 ;;=4^C44.320
 ;;^UTILITY(U,$J,358.3,5256,2)
 ;;=^5001046
 ;;^UTILITY(U,$J,358.3,5257,0)
 ;;=C44.321^^32^343^8
 ;;^UTILITY(U,$J,358.3,5257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5257,1,3,0)
 ;;=3^SCC Skin Nose
 ;;^UTILITY(U,$J,358.3,5257,1,4,0)
 ;;=4^C44.321
 ;;^UTILITY(U,$J,358.3,5257,2)
 ;;=^5001047
 ;;^UTILITY(U,$J,358.3,5258,0)
 ;;=C44.42^^32^343^16
 ;;^UTILITY(U,$J,358.3,5258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5258,1,3,0)
 ;;=3^SCC Skin Scalp/Neck
 ;;^UTILITY(U,$J,358.3,5258,1,4,0)
 ;;=4^C44.42
 ;;^UTILITY(U,$J,358.3,5258,2)
 ;;=^340477
 ;;^UTILITY(U,$J,358.3,5259,0)
 ;;=C44.520^^32^343^1
 ;;^UTILITY(U,$J,358.3,5259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5259,1,3,0)
 ;;=3^SCC Anal Skin
 ;;^UTILITY(U,$J,358.3,5259,1,4,0)
 ;;=4^C44.520
 ;;^UTILITY(U,$J,358.3,5259,2)
 ;;=^5001057
 ;;^UTILITY(U,$J,358.3,5260,0)
 ;;=C44.521^^32^343^2
 ;;^UTILITY(U,$J,358.3,5260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5260,1,3,0)
 ;;=3^SCC Skin Breast
 ;;^UTILITY(U,$J,358.3,5260,1,4,0)
 ;;=4^C44.521
 ;;^UTILITY(U,$J,358.3,5260,2)
 ;;=^5001058
 ;;^UTILITY(U,$J,358.3,5261,0)
 ;;=C44.529^^32^343^9
 ;;^UTILITY(U,$J,358.3,5261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5261,1,3,0)
 ;;=3^SCC Skin Oth Part of Trunk
 ;;^UTILITY(U,$J,358.3,5261,1,4,0)
 ;;=4^C44.529
 ;;^UTILITY(U,$J,358.3,5261,2)
 ;;=^5001059
 ;;^UTILITY(U,$J,358.3,5262,0)
 ;;=C44.622^^32^343^15
 ;;^UTILITY(U,$J,358.3,5262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5262,1,3,0)
 ;;=3^SCC Skin Right Upper Limb
 ;;^UTILITY(U,$J,358.3,5262,1,4,0)
 ;;=4^C44.622
 ;;^UTILITY(U,$J,358.3,5262,2)
 ;;=^5001070
 ;;^UTILITY(U,$J,358.3,5263,0)
 ;;=C44.629^^32^343^6
 ;;^UTILITY(U,$J,358.3,5263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5263,1,3,0)
 ;;=3^SCC Skin Left Upper Limb
 ;;^UTILITY(U,$J,358.3,5263,1,4,0)
 ;;=4^C44.629
 ;;^UTILITY(U,$J,358.3,5263,2)
 ;;=^5001071
 ;;^UTILITY(U,$J,358.3,5264,0)
 ;;=C44.722^^32^343^14
 ;;^UTILITY(U,$J,358.3,5264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5264,1,3,0)
 ;;=3^SCC Skin Right Lower Limb
 ;;^UTILITY(U,$J,358.3,5264,1,4,0)
 ;;=4^C44.722
 ;;^UTILITY(U,$J,358.3,5264,2)
 ;;=^5001082
 ;;^UTILITY(U,$J,358.3,5265,0)
 ;;=C44.729^^32^343^5
 ;;^UTILITY(U,$J,358.3,5265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5265,1,3,0)
 ;;=3^SCC Skin Left Lower Limb
 ;;^UTILITY(U,$J,358.3,5265,1,4,0)
 ;;=4^C44.729
 ;;^UTILITY(U,$J,358.3,5265,2)
 ;;=^5001083
 ;;^UTILITY(U,$J,358.3,5266,0)
 ;;=C44.82^^32^343^10
 ;;^UTILITY(U,$J,358.3,5266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5266,1,3,0)
 ;;=3^SCC Skin Overlapping Sites
 ;;^UTILITY(U,$J,358.3,5266,1,4,0)
 ;;=4^C44.82
 ;;^UTILITY(U,$J,358.3,5266,2)
 ;;=^5001089
 ;;^UTILITY(U,$J,358.3,5267,0)
 ;;=L57.8^^32^343^22
 ;;^UTILITY(U,$J,358.3,5267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5267,1,3,0)
 ;;=3^Skin Changes d/t Chr Exposure to Nonionizing Radiation
 ;;^UTILITY(U,$J,358.3,5267,1,4,0)
 ;;=4^L57.8
 ;;^UTILITY(U,$J,358.3,5267,2)
 ;;=^5009226
 ;;^UTILITY(U,$J,358.3,5268,0)
 ;;=L27.0^^32^343^23
 ;;^UTILITY(U,$J,358.3,5268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5268,1,3,0)
 ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
 ;;^UTILITY(U,$J,358.3,5268,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,5268,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,5269,0)
 ;;=L27.1^^32^343^24
 ;;^UTILITY(U,$J,358.3,5269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5269,1,3,0)
 ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
 ;;^UTILITY(U,$J,358.3,5269,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,5269,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,5270,0)
 ;;=L51.1^^32^343^29
 ;;^UTILITY(U,$J,358.3,5270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5270,1,3,0)
 ;;=3^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,5270,1,4,0)
 ;;=4^L51.1
 ;;^UTILITY(U,$J,358.3,5270,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,5271,0)
 ;;=L51.3^^32^343^30
 ;;^UTILITY(U,$J,358.3,5271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5271,1,3,0)
 ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
 ;;^UTILITY(U,$J,358.3,5271,1,4,0)
 ;;=4^L51.3
 ;;^UTILITY(U,$J,358.3,5271,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,5272,0)
 ;;=Z12.83^^32^343^19
 ;;^UTILITY(U,$J,358.3,5272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5272,1,3,0)
 ;;=3^Screening for Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,5272,1,4,0)
 ;;=4^Z12.83
 ;;^UTILITY(U,$J,358.3,5272,2)
 ;;=^5062696
 ;;^UTILITY(U,$J,358.3,5273,0)
 ;;=Z48.817^^32^343^33
 ;;^UTILITY(U,$J,358.3,5273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5273,1,3,0)
 ;;=3^Surgical Aftercare Following Skin Surgery
 ;;^UTILITY(U,$J,358.3,5273,1,4,0)
 ;;=4^Z48.817
 ;;^UTILITY(U,$J,358.3,5273,2)
 ;;=^5063054
 ;;^UTILITY(U,$J,358.3,5274,0)
 ;;=L94.0^^32^343^18
 ;;^UTILITY(U,$J,358.3,5274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5274,1,3,0)
 ;;=3^Scleroderma,Localized
 ;;^UTILITY(U,$J,358.3,5274,1,4,0)
 ;;=4^L94.0
 ;;^UTILITY(U,$J,358.3,5274,2)
 ;;=^5009470
 ;;^UTILITY(U,$J,358.3,5275,0)
 ;;=D23.9^^32^343^20
 ;;^UTILITY(U,$J,358.3,5275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5275,1,3,0)
 ;;=3^Sebaceous Hyperplasia
 ;;^UTILITY(U,$J,358.3,5275,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,5275,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,5276,0)
 ;;=L21.9^^32^343^21
 ;;^UTILITY(U,$J,358.3,5276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5276,1,3,0)
 ;;=3^Seborrhea,Unspec
 ;;^UTILITY(U,$J,358.3,5276,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,5276,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,5277,0)
 ;;=L91.8^^32^343^25
